Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125542571 | 12554257 | 1 | I | 201604 | 20160630 | 20160713 | 20160713 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201607002251 | ELI LILLY AND CO | 59.00 | YR | F | Y | 0.00000 | 20160707 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125542571 | 12554257 | 1 | PS | CETUXIMAB | CETUXIMAB | 1 | Unknown | UNK, WEEKLY (1/W) | N | 125084 | INJECTION | /wk | |||||||
| 125542571 | 12554257 | 2 | SS | CETUXIMAB | CETUXIMAB | 1 | Unknown | UNK, WEEKLY (1/W) | N | 125084 | INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125542571 | 12554257 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125542571 | 12554257 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125542571 | 12554257 | Decreased appetite | |
| 125542571 | 12554257 | Dermatitis acneiform | |
| 125542571 | 12554257 | Pruritus | |
| 125542571 | 12554257 | Somnolence | |
| 125542571 | 12554257 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125542571 | 12554257 | 1 | 201604 | 0 |